Amyloid-targeting treatment in Alzheimer's disease and concomitant antiplatelets: a clinical gray zone? - Quiz - MDSpire

Amyloid-targeting treatment in Alzheimer's disease and concomitant antiplatelets: a clinical gray zone?

  • By

  • Rus Prelog, Polona

  • Zupan, Matija

  • Kovacic, Alenka

  • Frol, Senta

  • Gregoric Kramberger, Milica

  • May 4, 2026

  • 0 min

Share

Original Source(s)

Amyloid-targeting treatment in Alzheimer's disease and concomitant antiplatelets: a clinical gray zone?

  • by Rus Prelog, Polona , Zupan, Matija , Kovacic, Alenka , Frol, Senta , Gregoric Kramberger, Milica

  • May 4, 2026

Related Content

Cognitive Trajectories and Subsequent Accelerometer-Measured Movement Behavior in Older Adults

Idiotypic-susceptible Alzheimer’s disease: a clinically relevant, neurofibrillary tangle subtype

Biomarkers, Cognitive Function, and Mortality in Centenarians